A citation-based method for searching scientific literature

Jing Chen, Xu Cao, Bolei Li, Zhangchen Zhao, Siqi Chen, Seigmund W T Lai, Sabina A Muend, Gianna K Nossa, Lei Wang, Weihua Guo, Jian Ye, Peter P Lee, Mingye Feng. Front Immunol 2021
Times Cited: 5







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Metabolic Interactions in the Tumor Microenvironment.
Costas A Lyssiotis, Alec C Kimmelman. Trends Cell Biol 2017
298
40

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
40



ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling-Driven Epithelial-to-Mesenchymal Transition.
Hsin-Jung Li, Feng-Yi Ke, Chia-Ching Lin, Mei-Yi Lu, Yi-Huei Kuo, Yi-Ping Wang, Kang-Hao Liang, Shin-Chang Lin, Ya-Hsuan Chang, Hsuan-Yu Chen,[...]. Cancer Res 2021
3
33

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
Daniel P Silver, Andrea L Richardson, Aron C Eklund, Zhigang C Wang, Zoltan Szallasi, Qiyuan Li, Nicolai Juul, Chee-Onn Leong, Diana Calogrias, Ayodele Buraimoh,[...]. J Clin Oncol 2010
660
20

Silencing Y-box binding protein-1 inhibits triple-negative breast cancer cell invasiveness via regulation of MMP1 and beta-catenin expression.
Jia Pei Lim, Sunitha Nair, Sukanya Shyamasundar, Pei Jou Chua, Umamaheswari Muniasamy, Ken Matsumoto, Jayantha Gunaratne, Boon Huat Bay. Cancer Lett 2019
19
20


The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway.
Maonan Wang, Manli Dai, Dan Wang, Ting Tang, Fang Xiong, Bo Xiang, Ming Zhou, Xiaoling Li, Yong Li, Wei Xiong,[...]. Cancer Lett 2021
8
20

YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT.
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, Christian Busch, Heike Niessner, Anja Schmitt, Stephan Forchhammer, Cornelia Grimmel, Peter R Mertens, Stephan Hailfinger,[...]. Mol Cancer Res 2018
22
20

Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States.
Dongya Jia, Jun Hyoung Park, Kwang Hwa Jung, Herbert Levine, Benny Abraham Kaipparettu. Cells 2018
89
20


LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.
Xiaoliu Du, Yiming Tu, Shuang Liu, Pengzhan Zhao, Zhongyuan Bao, Chong Li, Jinhao Li, Minhong Pan, Jing Ji. J Cell Mol Med 2020
17
20

Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis.
Amal M El-Naggar, Chansey J Veinotte, Hongwei Cheng, Thomas G P Grunewald, Gian Luca Negri, Syam Prakash Somasekharan, Dale P Corkery, Franck Tirode, Joan Mathers, Debjit Khan,[...]. Cancer Cell 2015
154
20

Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes.
Alexandru Andrei Tirpe, Diana Gulei, Stefana Maria Ciortea, Carmen Crivii, Ioana Berindan-Neagoe. Int J Mol Sci 2019
72
20

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
20

CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1.
Yong Wang, Yiting Wang, Liang Xu, Xianqi Lu, Donghe Fu, Jing Su, Hua Geng, Guoxuan Qin, Ruibing Chen, Changyi Quan,[...]. Exp Cell Res 2018
21
20

Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling.
Kang-Yun Lee, Tai-Chih Kuo, Chih-Ming Chou, Wen-Jing Hsu, Wei-Cheng Lee, Jia-Zih Dai, Sheng-Ming Wu, Cheng-Wei Lin. Cells 2020
6
20

The Emerging Hallmarks of Cancer Metabolism.
Natalya N Pavlova, Craig B Thompson. Cell Metab 2016
20

Conditional deletion of Ahr alters gene expression profiles in hematopoietic stem cells.
John A Bennett, Kameshwar P Singh, Stephen L Welle, Lisbeth A Boule, B Paige Lawrence, Thomas A Gasiewicz. PLoS One 2018
10
20

Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Kang-Yun Lee, Pei-Wei Shueng, Chih-Ming Chou, Bo-Xing Lin, Mei-Hsiang Lin, Deng-Yu Kuo, I-Lin Tsai, Sheng-Ming Wu, Cheng-Wei Lin. Cancer Sci 2020
12
20

YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer.
Liuyu Xu, Hongyun Li, Longchao Wu, Shiming Huang. Oncotarget 2017
16
20

BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Weihong Niu, Yanwei Luo, Yao Zhou, Mengna Li, Chunchun Wu, Yumei Duan, Heran Wang, Songqing Fan, Zheng Li, Wei Xiong,[...]. J Exp Clin Cancer Res 2020
7
20

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
20

Hypoxia and Metabolism in Metastasis.
Tong Zhang, Caixia Suo, Chenyang Zheng, Huafeng Zhang. Adv Exp Med Biol 2019
27
20

Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Rama Krishna Nimmakayala, Frank Leon, Satyanarayana Rachagani, Sanchita Rauth, Palanisamy Nallasamy, Saravanakumar Marimuthu, Gautam K Shailendra, Yashpal S Chhonker, Seema Chugh, Ramakanth Chirravuri,[...]. Oncogene 2021
11
20

The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer.
Minakshi Gandhi, Matthias Groß, Jessica M Holler, Si'Ana A Coggins, Nitin Patil, Joerg H Leupold, Mathias Munschauer, Monica Schenone, Christina R Hartigan, Heike Allgayer,[...]. Nat Commun 2020
19
20

LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1.
Xiangying Deng, Wei Xiong, Xianjie Jiang, Shanshan Zhang, Zheng Li, Yanhong Zhou, Bo Xiang, Ming Zhou, Xiaoling Li, Guiyuan Li,[...]. Cell Death Dis 2020
12
20

Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities.
Nathan J Lanning, Joshua P Castle, Simar J Singh, Andre N Leon, Elizabeth A Tovar, Amandeep Sanghera, Jeffrey P MacKeigan, Fabian V Filipp, Carrie R Graveel. Cancer Metab 2017
66
20

Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression.
Shengnan Wang, Lingyu Ma, Ziyuan Wang, Huiwen He, Huilin Chen, Zhaojun Duan, Yuyang Li, Qin Si, Tsung-Hsien Chuang, Chong Chen,[...]. Front Oncol 2021
2
50

Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer.
Dong Hui Cho, Se Kyung Lee, Sangmin Kim, Min-Young Choi, Seung Pil Jung, Jeonghui Lee, Jiyoung Kim, Min Young Koo, Soo Youn Bae, Jung-Han Kim,[...]. J Korean Surg Soc 2013
1
100

Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
Ninadh M D'Costa, Matthew R Lowerison, Peter A Raven, Zheng Tan, Morgan E Roberts, Raunak Shrestha, Matthew W Urban, Cesar U Monjaras-Avila, Htoo Zarni Oo, Antonio Hurtado-Coll,[...]. J Exp Clin Cancer Res 2020
10
20

Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment.
Tai-Hua Tsai, Ching-Chieh Yang, Tai-Chih Kou, Chang-En Yang, Jia-Zih Dai, Chia-Ling Chen, Cheng-Wei Lin. J Cell Physiol 2021
3
33

Fucoidan from Laminaria japonica exerts antitumor effects on angiogenesis and micrometastasis in triple-negative breast cancer cells.
Wen-Jing Hsu, Mei-Hsiang Lin, Tai-Chih Kuo, Chih-Ming Chou, Fwu-Long Mi, Chia-Hsiung Cheng, Cheng-Wei Lin. Int J Biol Macromol 2020
26
20

Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.
Érika Cosset, Sten Ilmjärv, Valérie Dutoit, Kathryn Elliott, Tami von Schalscha, Maria F Camargo, Alexander Reiss, Toshiro Moroishi, Laetitia Seguin, German Gomez,[...]. Cancer Cell 2017
71
20

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer.
Yang Li, Lihua Zou, Qiyuan Li, Benjamin Haibe-Kains, Ruiyang Tian, Yan Li, Christine Desmedt, Christos Sotiriou, Zoltan Szallasi, J Dirk Iglehart,[...]. Nat Med 2010
235
20

The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway.
Xiufen Zheng, Junying Zhang, Tian Fang, Xiaoxiao Wang, Siwei Wang, Zhifei Ma, Youtao Xu, Chencheng Han, Mengting Sun, Lin Xu,[...]. Oncogenesis 2020
13
20

Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.
Michihiko Kuwano, Tomohiro Shibata, Kosuke Watari, Mayumi Ono. Cancer Sci 2019
37
20

CCR 20th Anniversary Commentary: Triple-Negative Breast Cancer in 2015—Still in the Ballpark.
Steven A Narod, Rebecca A Dent, William D Foulkes. Clin Cancer Res 2015
7
20

Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.
Chih-Chia Kuo, Hsiang-Hsi Ling, Ming-Chen Chiang, Chu-Hung Chung, Wen-Ying Lee, Cheng-Ying Chu, Yu-Chih Wu, Cheng-Hsun Chen, Yi-Wen Lai, I-Lin Tsai,[...]. Theranostics 2019
27
20

Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
Bas Kreike, Hans Halfwerk, Petra Kristel, Annuska Glas, Hans Peterse, Harry Bartelink, Marc J van de Vijver. Clin Cancer Res 2006
45
20

A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Renaud Sabatier, Pascal Finetti, Nathalie Cervera, Eric Lambaudie, Benjamin Esterni, Emilie Mamessier, Agnès Tallet, Christian Chabannon, Jean-Marc Extra, Jocelyne Jacquemier,[...]. Breast Cancer Res Treat 2011
182
20

The Role of YB1 in Renal Cell Carcinoma Cell Adhesion.
Yong Wang, Jing Su, Donghe Fu, Yiting Wang, Yajing Chen, Ruibing Chen, Guoxuan Qin, Jing Zuo, Dan Yue. Int J Med Sci 2018
13
20


Genomic Signature of the Standardized Uptake Value in 18F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer.
Seon-Kyu Kim, Sung Gwe Ahn, Jeong-Yeon Mun, Mi-So Jeong, Soong June Bae, Ju-Seog Lee, Joon Jeong, Sun-Hee Leem, In-Sun Chu. Cancers (Basel) 2020
6
20

A novel long noncoding RNA, TMEM92-AS1, promotes gastric cancer progression by binding to YBX1 to mediate CCL5.
Shubin Song, Xuezhi He, Jing Wang, Hongtao Song, Yimin Wang, Yansong Liu, Zhengbo Zhou, Zhiyong Yu, Dengshun Miao, Yingwei Xue. Mol Oncol 2021
5
20

Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target.
Pramod Kumar Maurya, Alok Mishra, Birendra Singh Yadav, Swati Singh, Prashant Kumar, Amit Chaudhary, Shweta Srivastava, Suriya Narayan Murugesan, Ashutosh Mani. J Cancer 2017
33
20

Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription.
Shi-Jiang Deng, Heng-Yu Chen, Zeng Ye, Shi-Chang Deng, Shuai Zhu, Zhu Zeng, Chi He, Ming-Liang Liu, Kang Huang, Jian-Xin Zhong,[...]. Oncogene 2018
96
20

A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line.
Annette Lasham, Sunali Y Mehta, Sandra J Fitzgerald, Adele G Woolley, James I Hearn, Daniel G Hurley, Igor Ruza, Michael Algie, Andrew N Shelling, Antony W Braithwaite,[...]. Int J Cancer 2016
25
20

Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition.
Valentina Evdokimova, Cristina Tognon, Tony Ng, Peter Ruzanov, Natalya Melnyk, Dieter Fink, Alexey Sorokin, Lev P Ovchinnikov, Elai Davicioni, Timothy J Triche,[...]. Cancer Cell 2009
312
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.